J3403 Revakinagene taroretcel-lwey, per implant

Billable / valid for submission HCPCS Release 2026Q3

Short description: Revakinagene, per implant

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Revakinagene taroretcel-lwey, per implant	yes

J3401 Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
J3402 Injection, remestemcel-l-rknd, per therapeutic dose
J3404 Injection, zopapogene imadenovec-drba suspension, per therapeutic dose
J3405 Injection, onasemnogene abeparvovec-brve, per treatment
J3410 Injection, hydroxyzine hcl, up to 25 mg
J3411 Injection, thiamine hcl, 100 mg
J3415 Injection, pyridoxine hcl, 100 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
J3424 Injection, hydroxocobalamin, intravenous, 25 mg
J3425 Injection, hydroxocobalamin, intramuscular, 10 mcg
J3430 Injection, phytonadione (vitamin k), per 1 mg
J3465 Injection, voriconazole, 10 mg
J3470 Injection, hyaluronidase, up to 150 units
J3471 Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)
J3472 Injection, hyaluronidase, ovine, preservative free, per 1000 usp units
J3473 Injection, hyaluronidase, recombinant, 1 usp unit
J3475 Injection, magnesium sulfate, per 500 mg
J3480 Injection, potassium chloride, per 2 meq
J3485 Injection, zidovudine, 10 mg
J3486 Injection, ziprasidone mesylate, 10 mg